So according to their claims, everyone who was reported so far is living with a relatively high risk of developing SLE. Really? Call me a skeptic, but I kinda doubt that.We investigated the C4 gene CNV in 1,241 European Americans, including patients with systemic lupus erythematosus (SLE), their first-degree relatives, and unrelated healthy subjects, by definitive genotyping and phenotyping techniques. The gene copy number (GCN) varied from 2 to 6 for total C4, from 0 to 5 for C4A, and from 0 to 4 for C4B. Four copies of total C4, two copies of C4A, and two copies of C4B were the most common GCN counts, but each constituted only between one-half and three-quarters of the study populations. Long C4 genes were strongly correlated with C4A (R=0.695; P<.0001). Short C4 genes were correlated with C4B (R=0.437; P<.0001). In comparison with healthy subjects, patients with SLE clearly had the GCN of total C4 and C4A shifting to the lower side. The risk of SLE disease susceptibility significantly increased among subjects with only two copies of total C4
And if the gene copy number of 2 is so uncommon, why is it so common here?
The problem with the current state of understanding of these data (in general) and what they represent is that science's understanding is far too shallow and too limited to be of much practical use for helping to guide decision-making processes regarding important lifestyle changes.
Maybe it's just me but it seems that there are so many aspects of medical science where information is virtually exploding these days. But the analysis of these data is where the rubber meets the road, and that segment of the industry seems to be having a mighty tough time unsuccessfully trying to keep up. Many (actually most) of the conclusions that are published won't stand up to careful scrutiny in the light of day.
But it's all interesting, and playing with this stuff is how we learn.
Tex